Sign In

Login

Password

Forgot Password ? Sign Up

Vogliboza (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vogliboza" in Serbian language version.

refsWebsite
Global rank Serbian rank
8doi.org
2nd place
4th place
7nih.gov
4th place
8th place
1harvard.edu
18th place
28th place

doi.org (Global: 2nd place; Serbian: 4th place)

  • Aso Y, Yamamoto R, Suetsugu M, Matsumoto S, Wakabayashi S, Matsutomo R, Takebayashi K, Inukai T: Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes. Diabet Med. Aso, Y.; Yamamoto, R.; Suetsugu, M.; Matsumoto, S.; Wakabayashi, S.; Matsutomo, R.; Takebayashi, K.; Inukai, T. (септембар 2007). „Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes”. Diabetic Medicine : A Journal of the British Diabetic Association. 24 (9): 962—8. PMID 17509067. doi:10.1111/j.1464-5491.2007.02204.x. . Epub 2007 May 17.
  • Kurebayashi S, Watada H, Tanaka Y, Kawasumi M, Kawamori R, Hirose T: Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study. Endocr J. Kurebayashi, S.; Watada, H.; Tanaka, Y.; Kawasumi, M.; Kawamori, R.; Hirose, T. (април 2006). „Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study”. Endocrine Journal. 53 (2): 213—7. PMID 16618980. doi:10.1507/endocrj.53.213. 
  • Satoh N, Shimatsu A, Yamada K, Aizawa-Abe M, Suganami T, Kuzuya H, Ogawa Y: An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients. Metabolism. Satoh, N.; Shimatsu, A.; Yamada, K.; Aizawa-Abe, M.; Suganami, T.; Kuzuya, H.; Ogawa, Y. (јун 2006). „An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients”. Metabolism: Clinical and Experimental. 55 (6): 786—93. PMID 16713439. doi:10.1016/j.metabol.2006.01.016. 
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 
  • Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e. 

harvard.edu (Global: 18th place; Serbian: 28th place)

adsabs.harvard.edu

  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

  • Aso Y, Yamamoto R, Suetsugu M, Matsumoto S, Wakabayashi S, Matsutomo R, Takebayashi K, Inukai T: Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes. Diabet Med. Aso, Y.; Yamamoto, R.; Suetsugu, M.; Matsumoto, S.; Wakabayashi, S.; Matsutomo, R.; Takebayashi, K.; Inukai, T. (септембар 2007). „Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes”. Diabetic Medicine : A Journal of the British Diabetic Association. 24 (9): 962—8. PMID 17509067. doi:10.1111/j.1464-5491.2007.02204.x. . Epub 2007 May 17.
  • Kurebayashi S, Watada H, Tanaka Y, Kawasumi M, Kawamori R, Hirose T: Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study. Endocr J. Kurebayashi, S.; Watada, H.; Tanaka, Y.; Kawasumi, M.; Kawamori, R.; Hirose, T. (април 2006). „Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study”. Endocrine Journal. 53 (2): 213—7. PMID 16618980. doi:10.1507/endocrj.53.213. 
  • Satoh N, Shimatsu A, Yamada K, Aizawa-Abe M, Suganami T, Kuzuya H, Ogawa Y: An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients. Metabolism. Satoh, N.; Shimatsu, A.; Yamada, K.; Aizawa-Abe, M.; Suganami, T.; Kuzuya, H.; Ogawa, Y. (јун 2006). „An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients”. Metabolism: Clinical and Experimental. 55 (6): 786—93. PMID 16713439. doi:10.1016/j.metabol.2006.01.016. 
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.